Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05908123 · ClinicalTrials.gov registry record · NA

Exploring the Nature, Assessment and Treatment of Stuttering

A NA study of Stuttering and Stuttering, Adult, sponsored by University of Texas at Austin.

Recruiting
Registry status
NA
Development phase
3,000
Enrollment target
1
Study location

NCT05908123: Recruiting NA study of Stuttering and Stuttering, Adult, sponsored by University of Texas at Austin.

NCT05908123 is a NA study of Stuttering and Stuttering, Adult that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 3,000 participants, above the 276-participant average among 6 other Stuttering trials with a reported enrollment target (987% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05908123, a NA study of Stuttering and Stuttering, Adult, is actively recruiting participants, sponsored by University of Texas at Austin.

RECRUITING
Registry status
NA
Development phase
3,000 participants
Enrollment target
1
Study location

Study Summary

The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training specific to fluency disorders.

Primary Outcome

psychometric measures of communication competence (e.g., CARE Assessment: Communication Subscale)

Interventions

  • BEHAVIORAL The Blank Center CARE Model(TM) for Individuals who Stutter

Study Locations (1)

Texas

  • Arthur M. Blank Center for Stuttering Education and Research - Austin

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2015-05-22
Est. Completion 2035-05-22
Phase NA
University of Texas at Austin

257 total trials

What NCT05908123 shows while recruiting

NCT05908123 is an interventional study that assigns participants to a tested intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 276-participant average among 6 other Stuttering trials with a reported enrollment target (987% higher).

The record links to 4 conditions, with Stuttering appearing as the primary indexed condition, and to 1 intervention - of which The Blank Center CARE Model(TM) for Individuals who Stutter is the first listed.

NCT05908123 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05908123 about?

NCT05908123 is a clinical study titled "Exploring the Nature, Assessment and Treatment of Stuttering". The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical trainin...

What is the current status of trial NCT05908123?

This trial is currently recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2015-05-22. Estimated completion is 2035-05-22.

What conditions does trial NCT05908123 study?

This clinical trial studies the following conditions: Stuttering, Stuttering, Adult, Stuttering, Childhood, Stuttering, Developmental.

What interventions are being tested in trial NCT05908123?

The interventions under investigation include: The Blank Center CARE Model(TM) for Individuals who Stutter (BEHAVIORAL).

Who is sponsoring clinical trial NCT05908123?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05908123 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stuttering

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004847 · 3,000 participants · Phase 1

    Diagnosis of Pheochromocytoma

  • NCT00478712 · 3,000 participants

    Hirschsprung Disease Genetic Study

  • NCT00579566 · 3,000 participants

    Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • NCT00816114 · 3,000 participants

    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05908123, the US trial registry maintained by the National Library of Medicine. NCT05908123 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.